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ABSTRACT 
 
 
Cyclic peptide architectures can be easily synthesized from cysteine-containing peptides with appending 
maleimides, free or protected, through an intramolecular Michael-type reaction. After peptide assembly, the peptide 
can cyclize either during the trifluoroacetic acid treatment, if the maleimide is not protected, or upon deprotection of 
the maleimide. The combination of free and protected maleimide moieties and two orthogonally protected cysteines 
gives access to structurally different bicyclic peptides with isolated or fused cycles. 
Cyclization has been long recognized to provide 
peptides with increased stability to enzymatic degradation 
and better cell permeability (see 1 for recent reviews). 
Cyclization imposes structural constraints and allows for 
structural preorganization of functional groups, but the 
degree of flexibility still permitted is expected to enhance 
and facilitate interaction with the receptor target. In 
addition to their potential role as enzyme inhibitors, cyclic 
peptides are considered useful tools to interrogate 
complex structures, and show promise to interfere with 
protein-protein interactions.1 Cyclic peptides can also 
mimic protein loops. In this respect, appending 
conformationally constrained peptides from a scaffold can 
simulate the distribution of protein loops in space,2 and 
this is of interest for immunological studies. In a different 
context, a Zinc-finger-type phosphorylated peptide with a 
cycle formed by metal chelation was able to distinguish 
between DNAs incorporating one of the two cytosines 
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involved in epigenetic regulation, namely 5-
hydroxymethylcytosine and 5-methylcytosine.3 
Peptide macrocycles can be obtained by bridging the 
two ends of the peptide chain (head-to-tail), internal 
positions, or both. Chemical synthesis has provided the 
most frequently occurring natural bridges (disulfides, 
macrolactames, macrolactones),1,4 as well as rings with 
biaryls and diaryl ethers.5 Moreover, ring-closing 
metathesis, the Cu(I)-catalyzed azide-alkyne 
cycloaddition,1,4 the reaction between a nucleophile and 
an activated pyridine-N-oxide6 and sulfur-mediated 
reactions7 have also afforded peptide cycles. When the 
latter involve a thiol and an alkene, thioether formation 
may take place either through radical8 or Michael-type 
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Scheme 1. First syntheses of a cyclic peptide (a) and assessment of cyclization (b). 
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processes.9 Even though the addition of a thiol to a 
maleimide is one of the oldest and most extensively used 
"click" reactions, it has hardly ever been exploited to 
obtain cyclic biomolecules.10 There is one report dealing 
with the on-resin cyclization of a peptide incorporating 
an N-terminal maleimide,10a and a very recent one on the 
synthesis of cyclic oligonucleotides.10b In this manuscript 
we describe its application to the preparation of peptide 
monocycles and bicycles in solution. 
To prove the suitability of the thiol-ene Michael 
reaction for this purpose, peptide sequence KYAYCG 
was assembled on the Rink amide resin (Scheme 1a, for 
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details see Supplementary Information). Maleimides are 
labile to nucleophilic bases and thus not compatible with 
the piperidine treatments that remove the Fmoc group in 
standard Fmoc/tBu peptide chemistry. Hence, the 
maleimide moiety has to be incorporated either after the 
chain has been fully assembled, or during chain 
elongation provided that it is protected.11 For comparison 
purposes, part of the protected peptide-resin was 
derivatized with 3-maleimidopropanoic acid (1), and 
part with 3-[2,5-dimethylfuran protected 
maleimido]propanoic acid (2).12Trifluoroacetic acid 
treatment of peptide-resin 3 provided a crude whose 
main product (Figure S1) was isolated and treated with 
H2O2 to investigate whether it was linear (6) or circular 
(7). Under the reaction conditions,12 the free thiol of the 
linear precursor (6) is oxidized to sulfonic acid (mass 48 
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units higher), whereas the thioether of the cyclic 
compound becomes a sulfoxide (mass 16 units higher). 
After treatment with H2O2 it was found that the main 
product in the crude was the sulfoxide of the cyclic 
molecule (7-SO, Scheme 1b), which showed that the 
Michael-type thiol-maleimide reaction can take place 
even in the strongly acidic deprotection medium, either 
during the deprotection procedure or upon elimination of 
the deprotecting mixture when the solution becomes 
more concentrated. 7 Was found to be accompanied by 
some cyclic dimeric and trimeric peptides (about 24 % 
in the crude, see Figure S1). 
Acidolysis (trifluoroacetic acid) of peptide-resin 4 
removed permanent protecting groups on the peptide, 
affording [protected maleimido]-peptide 5 (Scheme 1a). 
The maleimide was then deprotected by heating in a 
microwave oven at 90 oC. In agreement with previous 
results,10,11 the retro!Diels-Alder reaction and cyclization 
took place simultaneously, furnishing a thiosuccinimide 
that remained stable to the heating conditions. 
Different peptide concentrations were tested to 
examine under which maleimide deprotection conditions 
the target monocycle 7 was exclusively formed from 5, 
or at least formation of 7 was favored over that of 
oligomers. As summarized in Table S1 (see also Figure 
S3), in no case was it possible to fully prevent formation 
of the cyclic dipeptide. Yet, in concentrations below 1 
mM the extent of cyclic dimer formation did not exceed 
5 %, and formation of cyclic tripeptide was virtually nil. 
Hence, protection of the maleimide allows for a higher 
control of the dilution conditions in which cyclization 
takes place, so that fully protected [maleimido peptide]-
resins such as 4 are better precursors of peptide rings 
than peptide-resins with a free maleimide such as 3. 
Moreover, the overall yield of the 4 " 7 process (21 %, 
two steps with two purifications) was higher than that of 
the 3 " 7 transformation (12 %, one purification). 
Cyclic peptides of larger size and incorporating 
different amino acids were then prepared (Figure 1). The 
amino acid sequence of 8 (9 amino acid-cycle) 
reproduces most of the sequence of antibiotic 
tyrocidine,13 and 9 (12 amino acid-cycle) reproduces the 
loop sequence of an oxidoreductase (dihydrolipoamide 
dehydrogenase, UNiProtKb P09063).14 10 Was 
synthesized to assess whether histidine interferes with 
the thiol-maleimide reaction, since it has been described 
that N-terminal maleimido-derivatized, histidine-
containing peptides can easily undergo an intramolecular 
imidazole-maleimide Michael-type reaction.15 However, 
N-terminal maleimido-derivatized, histidine-containing 
peptides have been successfully used in 
conjugationswith thiol-derivatized oligonucleotides.16 
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Cyclic peptides 8 and 9 were prepared by attaching 2 
to the peptide-resin. Compound 11 (Figure 1, ref. 11), in 
which the protected maleimide moiety is linked to the 
side chain of lysine, was used for the synthesis of 10. In 
all cases solid-phase assembly was first followed by an 
acidolytic treatment to remove protecting groups on the 
peptide chain, and after purification the retro!Diels-
Alder reaction that deprotects the maleimide was carried 
out. As in the case of 7, the latter was accompanied by 
cyclization, as assessed by reaction with H2O2. These 
experiments showed that the thiol-maleimide reaction 
provides peptide cycles with at least 12 amino acids with 
very good [maleimide deprotection+cyclization] yields 
(# 50 %), both with head-to-side chain and side chain-to-
side chain linkages, and including a variety of 
trifunctional amino acids. They also showed that 
histidine-containing peptides can be cyclized making use 
of the Michael-type reaction even if the histidine residue 
is very close to the maleimide unit. In agreement with 
other authors' results,8 cyclic peptides were found to 
elute before the linear precursors upon HPLC analysis. 
 
Figure 1. Structures of cyclic peptides 8-10, and of the lysine 
derivative 11 used in the synthesis of 10, 14 and 17). 
N
O
OS
Cys
NH2
Pro
Orn
Phe
Val
DPhe
Tyr
Asn
Gln
8
N
O
OS
Cys
NH2
Glu
Asp
Ala
Tyr Thr
Arg Glu
Pro
Arg
Leu
Ile
9
H His Lys
O O
S
Tyr
Cys
Gly
Gly
Arg
10
FmocNH
N
O
O
O
H
H11
COOH
NH (CH2)2
O
(CH2)4
 
 
To further explore the scope of the method two 
bicyclic peptides, 14 and 17 (Scheme 2), were 
synthesized. In the former ("spectacles-like") the two 
cycles are separated by two residues of the peptide 
chain, while in the latter the cycles have part of the chain 
in common. For their preparation we combined 3-
maleimidopropanoic acid (1), the lysine derivative 11, 
and two orthogonally protected cysteine residues, 
Cys(Trt) and Cys(S-tBu). Since 1 can only be installed at 
the N-terminal (see above), by adequately placing the 
other three residues either type of bicycle can be 
obtained. 
Trifluoroacetic acid treatment of peptide-resins 12 and 
15 removed all protecting groups except those of Cys(S-
tBu) and the maleimido-derivatized lysine, so that 
reaction between the N-terminal maleimide and the free 
thiol furnished the first cycle (compounds 13 and 16, 
respectively). The S-tBu group was subsequently 
removed from the still protected cysteine residue by 
reaction with tris(carboxyethyl)phosphine. After 
purification to remove excess phosphine and prevent 
reaction between the phosphine and the maleimide,10 
heating in a microwave oven deprotected the maleimide 
attached to the lysine side chain and promoted the 
second cyclization. In both cases the target bicycle (14 
or 17) was obtained. With this sequence of steps it is not 
possible to prevent formation of oligomeric cyclic 
peptides during the first cyclization. 
 
Scheme 2. Synthesis of bicyclic peptides with either two peptide-linked rings (a), or two cycles with shared amino acids (b). 
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In summary, the Michael-type thiol-maleimide 
reaction is a straightforward procedure for the synthesis 
of cyclic peptides. If the peptide is appended with a free 
maleimide, cyclization takes place during the acid-
promoted removal of peptide protecting groups, and 
formation of some cyclic dimers and trimers cannot be 
fully avoided. In case the peptide is derivatized with a 
2,5-dimethylfuran-protected maleimide, which can be 
placed anywhere in the sequence, cyclization and 
maleimide deprotection take place simultaneously and in 
good yield, and formation of oligomers can be kept to a 
much lower extent. The method has proved suitable to 
synthesize up to 43-membered rings. It is compatible 
with most trifunctional amino acids, namely those 
bearing hydroxyl, acid and basic functional groups.  
An adequate choice of the protection scheme allowed 
structurally different bicyclic peptides, with the two 
rings fused or isolated, to be obtained. For this purpose 
peptide chain precursors incorporated two differently 
protected cysteines, a free maleimide and a protected 
maleimide. 
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